FT : Pacifist Japan takes big step towards becoming major arms exporter

Pacifist Japan takes big step towards becoming major arms exporter
Australia’s landmark purchase of Mitsubishi frigates offers model for future sales of warships, missiles and radars

Australia’s choice of Mitsubishi Heavy Industries as its preferred supplier for a new batch of frigates marks a huge step in Japanese efforts to become a major arms exporter at a time of rising regional tensions and stretched defence supply chains.

But analysts warn that Japan will have to overcome production capacity and labour constraints to demonstrate it can offer a real alternative to the US, European and South Korean defence suppliers.

MHI’s $6.5bn frigate deal, which Tokyo and Canberra announced this week and expect to finalise early next year, would be the first international sale of a complete Japanese defence platform with lethal capabilities since the second world war and a model for future exports of warships, missiles and radar systems.

“This deal is a major breakthrough for Japan,” said Hirohito Ogi, a senior research fellow at the Institute of Geoeconomics and former defence ministry official. “This will further motivate the Japanese defence companies to seek other opportunities for international arms transactions.”

MHI’s success comes as arms contractors ride a surge in global defence spending fuelled by conflicts in Ukraine and the Middle East, and as US allies in the Indo-Pacific strengthen their militaries to counter China’s increasing might.

Japan in 2014 lifted a self-imposed ban on almost all arms exports that had since the late 1960s restricted the country’s technologically powerful industrial groups to supplying its Self-Defense Forces.

But big deals have proved elusive since Japan lost out to France on a $35bn submarine supply deal from Australia in 2016.

Ogi said a major difference this time was that “the current international arms market is characterised by a lack of supply capacity”.

“The US cannot meet all the demands of its allies for its weapons,” he said. “Australia needed the capabilities that Japan could provide.”

Analysts said Japan’s defence industry had learned from the previous failure to tailor its product to Australia’s needs. The private sector also gave its support to a more sophisticated government campaign.

MHI offered an upgraded version of its Mogami-class frigate, which only requires 90 crew members — compared with the 120 needed on the vessel proposed by Germany’s Thyssenkrupp — yet is bigger, allowing the longer cruising range and larger weapons capacity Canberra wanted.

Japan was also able to guarantee delivery of the first vessel by 2029, plugging a gap caused by the retirement of Australia’s existing Anzac-class frigates, and could promise interoperability with the US Navy.

Despite a higher upfront price, the Australian government insisted Japan’s warships would be cheaper when their lower weapons and personnel costs, as well as longer hull life, were factored in.

Jennifer Parker, an associate at the Australian National University’s National Security College and former naval officer, said Japan’s frigates were “clearly, on paper, the best ship” for Australia.

Japan is under consideration to co-operate on undersea autonomous technologies under pillar two of Aukus — the trilateral security pact between Australia, the UK and the US. Given that, Masashi Murano, senior fellow with the Hudson Institute’s Japan chair, said its selection to build the frigate took on a “broader significance” as Tokyo and Canberra were likely to deepen collaboration on stealth technologies.

Tokyo is already developing a fighter jet with the UK and Italy that the three countries hope to sell internationally to recoup development costs. Japan also possesses significant capabilities in advanced air defence missiles and space technologies, all potential candidates for export.

In 2023, Japan amended its arms export rules to allow the shipment of Patriot air defence missiles to the US so that Washington could send its own stocks to Ukraine.

However, arms exports remain a sensitive political issue in the constitutionally pacifist country. The government still only allows the export of lethal weapons under conditions such as requiring the importing country not to be involved in an active conflict.

It may also be a challenge for Japanese arms suppliers to find sufficient production capacity for exports, as domestic demand is spurred by a planned rise in defence spending to 2 per cent of GDP by 2027, up from 1.8 per cent.

Yoshinori Kanehana, chair of Kawasaki Heavy Industries, said in January that the defence sector was “suffering” from red-hot orders. He cited annual orders for the CH-47 Chinook helicopter that KHI produces under licence from Boeing jumping from six units in 2017 to 17 last year.

“We cannot build a factory in a short period,” he said, adding that it was managing with its existing production capabilities. “It is now time for us to increase capacity. We don’t have enough people. We need to train the people, take from the other divisions to train to do military planes, as well as hiring from outside, but it is very difficult.”

Japan will produce the first three of 11 frigates at home, with the remainder built in Australia with local partner Austal. Corey Wallace, associate professor at Kanagawa University, said that could be very challenging, given Japan’s lack of experience with overseas defence “maintenance, services and supply chain” management.

Parker at ANU warned that problems delivering the frigates could damage ties between Japan and Australia, which have been blossoming. But if MHI can deliver, Japan could carve itself a place in the global arms industry.

“There are a lot of tier-two or tier-three military powers that can’t afford US equipment,” said Wallace. “Japan now has a fantastic opportunity to dispel the external factors and perceptions that were limiting it from becoming a major arms exporter.”

FT : Scania to export half of trucks built at €2bn China plant

Scania to export half of trucks built at €2bn China plant
VW-owned group preparing for global influx of Chinese-made vehicles by staying close to cutting-edge technology

Scania intends to export half of the trucks to be built at its new €2bn plant in China as the Swedish group doubles down on manufacturing in the world’s largest commercial vehicle market despite rising geopolitical tensions.

Chief executive Christian Levin told the Financial Times that the Volkswagen-owned group was preparing for a wave of Chinese-made trucks by staying close to rivals who are producing cars in the country and competing fiercely on technology.

“China has more free trade agreements with countries in the world than the European Union. We will, of course, take advantage of any export opportunity,” Levin said in an interview.

At least half of the trucks manufactured at the plant in the eastern Chinese city of Rugao would be exported to Asia and Oceania, Levin said. The plant is set to begin production in October.

The investment — its biggest outside Sweden in six decades — makes Scania one of a select group of foreign vehicle manufacturers to have been granted a licence to operate a fully-owned plant in China, following in the footsteps of Tesla’s Shanghai gigafactory.

It also bucks a broader trend among western truckmakers, which have been reducing their exposure to the world’s largest commercial vehicle market. German rival Daimler Truck recently told the FT it would not rule out an exit from manufacturing in China, with chief executive Karin Rådström saying it was “not an easy market to be profitable in”.

Scania’s Rugao plant, an addition to its existing manufacturing facilities in Europe and Brazil, would offer the company greater flexibility in allocating production depending on the geopolitical situation, Levin said.

The group’s board signed off on the investment in order to stay close to the sector’s cutting-edge technology, as the group braces for Chinese truckmakers to make inroads to global markets in the same way as carmakers such as BYD have done.

“The Chinese manufacturers today are predominantly strong in China, but that’s today,” he said. “I’d rather take on the competition and try to beat them in their home market. And if we can do that well, then we know that we can do that well anywhere in the world.”

Scania has also persuaded Beijing that its efficient tailor-made manufacturing technology could help transform the country’s heavy vehicle industry. The Chinese government in turn has asked Scania to increase production quickly to its full capacity of 50,000 units.

“[It] has been very clear in the discussions with government officials on both local and central level that they would like Scania to bring a lot of cutting-edge technology that we have in our toolbox to China,” said Levin, describing the approval process as “swift”.

The investment comes as sales of diesel trucks in China have taken a hit following a shift to liquefied natural gas-powered vehicles, and a weakening domestic economy.

About 900,000 heavy-duty trucks were sold in China last year, according to the China Association of Automobile Manufacturers, down 44 per cent from a peak in 2020, as sales of diesel-powered trucks plunged. The top three best-selling truckmakers in the country are all state-owned companies, commanding a combined 60 per cent market share.

Levin said he was not expecting a major rebound in China’s overall heavy goods vehicle market, but predicted demand for premium transport would take off next year after Beijing tightens emission standards. It plans to offer diesel engines that can also run on biodiesel to reduce emissions.

However, Scania’s bet on China comes at a time when local rivals have big plans to electrify traditionally gas-guzzling juggernauts. Robin Zeng, founder of China’s battery group CATL, recently told the FT he expected half of all new trucks sold in the country to be electric by 2028.

Levin said trucks to be produced at the new China plant would feature a “Lego-like” design, which will allow internal combustion engines to be interchanged with battery packs inside a vehicle.

The first model to be produced in Scania’s Rugao factory will have an internal combustion engine. However, Levin said the company was in no hurry to commit capital to any single energy solution, until it becomes clear “which technology [would] be the standard and which one will win the race”.

FT : Google and IBM believe first workable quantum computer is in sight

Google and IBM believe first workable quantum computer is in sight
Recent breakthroughs have revived confidence about creating full-scale quantum systems by end of the decade

In the race to build a workable quantum computer — a dream at the intersection of advanced physics and computer science since the 1980s — the finish line may be in sight.

A spate of recent technical breakthroughs means that leading tech companies are vying to become the first to expand what until now have been a series of lab experiments into full-size, workable systems.

In June, IBM became the latest to claim its path was now clear to a full scale machine, after publishing a blueprint for a quantum computer that filled in key missing pieces from its earlier designs. Quantum computers hold the potential to solve problems beyond today’s machines in fields such as materials science and AI.

“It doesn’t feel like a dream anymore,” said Jay Gambetta, head of IBM’s quantum initiative. “I really do feel like we’ve cracked the code and we’ll be able to build this machine by the end of the decade.”

That has intensified a race against Google, which cleared one of the biggest remaining hurdles late last year and says it is also on course to build an industrial-scale quantum computer by the end of the decade.

“All the [remaining] engineering and scientific challenges are surmountable,” said Julian Kelly, head of hardware at Google Quantum AI.

Yet even as they put some of the hardest science problems behind them and gear up for a sprint to the finish line, the companies still face a raft of more routine-sounding but still difficult engineering problems to industrialise the technology.

The remaining hurdles “seem technically less challenging than the fundamental physics, but we should not underestimate that engineering effort to scale”, said Oskar Painter, the executive in charge of quantum hardware at Amazon Web Services. He predicted a useful quantum computer was still 15-30 years away.

Recommended

Reaching industrial scale means taking systems that comprise fewer than 200 qubits — the basic building blocks for quantum machines — and expanding them to 1mn qubits or more. The companies involved compare this to the early days of conventional computing, though quantum computers pose additional challenges.

Among the toughest is the inherent instability of qubits, which maintain their quantum states — when they can perform useful calculations — for only tiny fractions of a second. That leads to incoherence, or “noise”, as ever-larger numbers of qubits are added.

One graphic demonstration of the limits of scaling came when IBM increased the number of qubits in its experimental Condor chip to 433, leading to “crosstalk”, or interference, between the components.

Stacking larger numbers of qubits together like this “creates a bizarre effect we can’t control anymore”, said Subodh Kulkarni, chief executive of Rigetti Computing, a US start-up that also works with qubits made from superconductors, the same technology used by IBM and Google. “That’s a nasty physics problem to solve.”

Gambetta said IBM had anticipated the interference seen in its Condor chip, and that it had moved on to a new type of coupler to link its qubits, making its systems less susceptible to the problem.

In the first experimental systems, qubits have been “tuned” individually to improve their performance. Complexity and cost makes this impractical at larger scale, leading to a pursuit of more reliable components — something that will require steady improvements in manufacturing, as well as new breakthroughs in materials. Google also says it aims to bring down component costs by a factor of 10 to hit its target cost of $1bn for a full-scale machine.

The companies say their systems will be able to tolerate a degree of imperfection in the qubits thanks to a technique known as error correction. This works by copying data between a number of qubits, creating redundancy for when any individual component fails.

So far, only Google has demonstrated a quantum chip capable of performing error correction as its size increases. According to Kelly, any company trying to scale up without first reaching this point would end up with “a very expensive machine that outputs noise, and consumes power and a lot of people’s time and engineering effort and does not provide any value at all”.

Others, however, have not slowed their attempts to scale, even though none has yet matched Google.

IBM said its sights were set on what it called the most important challenge, of showing it can operate a system at very large scale, while also questioning whether Google’s approach to error correction will work in a full-sized system.

The technique used by Google, known as surface code, works by connecting each qubit in a two-dimensional grid to its nearest neighbours. This relies on a relatively large number of qubits working together and requires the system to reach 1mn qubits or more to perform useful calculations.

Microsoft has said it decided against pursuing a similar design after deciding that trying to build 1mn-qubit machines presented too many other engineering challenges.

IBM changed course to a different form of error correction, known as a low-density parity-check code, which it claims will require 90 per cent fewer qubits than Google. However, this depends on longer connections between qubits that are further apart, a difficult technology challenge that has left it behind.

Kelly at Google said IBM’s technique added new levels of complexity to systems that are already extremely hard to control, though IBM claimed last month to have succeeded in creating longer connectors for the first time.

The latest IBM design appeared capable of producing a workable, large-scale machine, said Mark Horvath, an analyst at Gartner, though he added that its approach still only existed in theory. “They need to show they can manufacture chips that can do that,” he said.

Regardless of design, the companies face many other common engineering challenges.

These include reducing the rat’s nest of wiring found inside early quantum systems by finding new ways to link large numbers of components into single chips, and then connecting a number of chips into modules. It will also require much bigger, specialised fridges to house full-scale systems, which operate at extremely low temperatures.

Issues like these highlight basic design decisions that could be critical as the systems scale. Ones that use superconductors as qubits, such as those from Google and IBM, have shown some of the biggest advances, though their qubits are harder to control and they need to operate at temperatures close to absolute zero.

Rival systems that use atoms as qubits — known as trapped ions and neutral atoms — or those that use photons promise to be inherently more stable. But they face several other hurdles, including the difficulty of linking their clusters of qubits together into larger systems and overcoming their slower computing speed.

The costs and technical challenges of trying to scale will probably show which are more practical.

Sebastian Weidt, chief executive at Universal Quantum, a British start-up working with trapped ions, said that government decisions about which technologies to back during this period would probably play a big part in narrowing investment down to “a smaller number of players who can get all the way”.

In one sign of growing official interest in sorting out the winners, Darpa, the Pentagon’s advanced research agency, last year began a broad study of different quantum companies with the aim of identifying which could be expanded to reach practical size the fastest.

Meanwhile, several companies have recently shown off radical new designs for qubits, which they say will be more controllable.

They include Amazon and Microsoft, which claims to have mastered a state of matter to create more reliable components. These technologies are at a far earlier stage of development but their backers claim they will eventually leap ahead.

That hasn’t slowed the companies using older techniques that have been years in development. “Just because it’s hard, doesn’t mean it can’t be done,” said Horvath at Gartner, echoing the confidence fuelling the industry’s race to scale.

FT : Daniel Loeb fights investors over plan to convert London vehicle into Cayma

Daniel Loeb fights investors over plan to convert London vehicle into Cayman insurer
Tussle is a test of new UK governance rules on related-party transactions

Billionaire activist Daniel Loeb is battling with shareholders to turn his London-listed company into a Cayman Islands-based reinsurer, testing new UK governance rules in a bid to manage money for American retirees.

In May, Loeb’s London-listed investment company Third Point Investors Limited (TPIL) announced plans to buy Malibu Life Reinsurance (Malibu Re) in a reverse takeover that would transform the investment vehicle into a reinsurer focused on the fast-growing US market for fixed annuities. 

The London vehicle was set up as a feeder fund giving investors access to the strategies of Loeb’s New York hedge fund Third Point, which separately created and capitalised Malibu Re. 

The proposed takeover has met a backlash from a group of TPIL investors, even after a July offer sweetened the deal.

“Dissenting shareholders have been trapped in this vehicle, against their will, to fund Third Point’s ambitions in reinsurance,” Tom Treanor of Asset Value Investors, which is part of the investor group opposed to the takeover, told the Financial Times.

Cayman vehicles are contentious because they are more lightly regulated and required to hold less capital to meet their obligations, compared with insurers based in Bermuda, a much larger offshore reinsurance destination.

The investor group, which includes Staude Capital and Metage Capital alongside AVI, said it was not satisfied even after Third Point raised its offer.

TPIL originally offered to acquire Malibu Re in an all-share deal that valued the reinsurer at about $68mn. It also proposed a potential tender offer for up to $75mn of TPIL shares, priced at a 12.5 per cent discount to net asset value.

In July, it replaced the tender offer with a redemption offer in which TPIL proposed to allow up to $136mn of shares to be redeemed at a narrower discount of about 5 per cent, although not all the payment would be upfront.

But the investor group complained that the deal was risky and that much of the upside could end up flowing to Loeb’s New York hedge fund, which manages assets for Malibu Re.

“Every alternative asset manager now has some sort of reinsurance or insurance client,” Treanor said. Deals to manage insurance inflows could be “incredibly lucrative” for asset managers, he said, but details on the plan for the combined business were scarce.

The results of a shareholder vote on the Malibu Re takeover are expected to be announced following a meeting on Thursday. Under the Financial Conduct Authority’s new rules for related-party transactions, which came into force last year, Loeb will be permitted to vote his 25 per cent stake in TPIL.

TPIL’s board said last month that it had irrevocable support from shareholders holding 45 per cent of the company’s voting rights — including Third Point itself — to back the deal.

One person involved in the deal said negative media coverage of the fight had become a cautionary tale against listing in London. “Do you think a company like this is now sitting here saying, ‘thank God we’re on the London Stock Exchange?’” they said.

Dimitri Goulandris, chair of the TPIL strategy committee, said: “The transaction offers a clear path to long-term shareholder value and represents a rare opportunity to bring a high-quality reinsurance platform to the London market.”

The board’s “fully independent strategy committee”, which included a representative of the investor group, had “reviewed a wide range of business and structural options” before making its recommendation, Goulandris said, describing the group’s claims of “poor governance and undisclosed conflicts of interest” as “fantastical”.

“The board’s duty is not to placate or prioritise the interests of one group of shareholders, but to act honestly and in good faith in what it believes to be the best interests of the company,” he added.

Under the new FCA rules, larger related-party deals require a sponsor of the transaction to give an opinion that the transaction is “fair and reasonable”. That view was given by Jefferies, the investment bank.

The dissenting investor group pointed to “the close personal and commercial relationships” between Jefferies and Third Point, and said it had raised ties between the groups to FCA regulators as a conflict of interest. Jefferies chief executive Rich Handler hired Loeb to work in the investment bank’s office in the 1990s.

Jefferies and Handler declined to comment.

FT : Rheinmetall chief says tanks to get cheaper despite defence spending surge

Rheinmetall chief says tanks to get cheaper despite defence spending surge
Germany’s biggest weapons maker says customers stand to benefit from economies of scale and more automation

The boss of Rheinmetall said the cost of tanks, armoured vehicles and artillery was set to fall in the coming years despite a surge in defence spending by European governments.

Responding to fears that ballooning European defence budgets would lead to price inflation and poor value for taxpayers, chief executive Armin Papperger told the Financial Times that the cost of its armoured vehicles and artillery systems “will go down and not up”.

The head of Germany’s largest weapons maker said economies of scale and greater use of automation “should be good for the company but it should be also good for the customers”.

The cost of ammunition was already falling after Rheinmetall expanded its ammunition production capacity tenfold over the past three years in response to surging demand, Papperger said.

Such economies of scale have been harder to achieve with tanks and armoured vehicles. However, he said the company expected “thousands and thousands” of orders for products such as its Boxer and Puma vehicles as well as the Leopard 2 tank — produced by the Franco-German KNDS but with a gun turret made by Rheinmetall — over the next 12 months.

That forecast included orders worth an estimated €30bn to €35bn for tanks and armoured vehicles from Germany alone after Chancellor Friedrich Merz promised to create the strongest conventional army in Europe and allowed unlimited borrowing to fund defence spending.

Rheinmetall is forecasting new orders worth about €80bn for the year to June 2026. Its order backlog stood at €55bn for the previous 12 months. “It is huge numbers,” Papperger said.

The company has emerged as one of the biggest winners from the surge in European defence spending in the wake of Vladimir Putin’s full-scale invasion of Ukraine in 2022. The stock has since soared, leaving the company worth €72bn.


The rocketing demand is all but certain to continue after European nations pledged to dramatically scale up their spending in response to Russian aggression and US pressure to shoulder more of the burden within Nato.

The spending spree has led to concerns among some economists that it could result in price inflation or even price gouging by defence companies. 


Papperger said Rheinmetall had “never, ever” asked for a price mark-up to compensate for the strong inflation that followed the coronavirus pandemic. 

He said he saw no risk of a backlash against arms makers even as nations such as Germany and the UK face painful decisions about cuts to social welfare at the same time as increasing military spending. 

“I don’t feel that at the moment,” he said. “We are able to deliver . . . If you deliver, you make the customer happy — and the customer is the government.”

>>> US After Hours Summary: BBAI -27.3%, PUBM -23%, CE -13.2%, FLNC -11.4% lower

After Hours Summary: BBAI -27.3%, PUBM -23%, CE -13.2%, FLNC -11.4% lower on earnings; WOW +46.9% to be taken private; HRB -0.8% names new CEO
After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: GEVO +47.2%, GDOT +16.5% (also files for $100 mln mixed securities shelf offering), HNRG +13.1%, MRVI +11.7%, ZIP +9.9%, LIF +7.8% (also names new CEO), MRCY +7.3%, ASTS +6.3%, RPAY +2.6% (also names new CFO), XENE +2.6%, USAR +1.4%, TBBB +0.7%, FWRD +0.3%, DNLI +0.1%

Companies trading higher in after hours in reaction to news: WOW +46.9% (to be taken private), KOPN +14.4% ($15 mln strategic investment from Theon; also signs licensing and development agreement), SBGI +13.5% (strategic review for its Broadcast business), BFIN +7.4% (FFBC to acquire BFIN), APO +5.2% (to acquire Trace3), IVZ +3.3% (reports July AUM), NVCT +2% (initiates Phase 1b Program for NXP900), JJSF +1.9% (increases dividend), AB +1.8% (reports July AUM), WERN +1.4% (authorizes new 5 mln share repurchase program), LTBR +1.3% (OKLO and LTBR announce collaboration to explore co-location of fuel fabrication facility), LRCX +0.7% (files mixed securities shelf offering), CACI +0.5% (awarded a $1.64 bln US Transportation Command contract), GD +0.5% (awarded a $322 mln modification to US Navy contract), VVX +0.2% (to acquire a data engineering, intel mission support and cyber business serving the intelligence community), MARA +0.2% (investment agreement allowing MARA to acquire a 64% stake in Exaion), ALB +0.1% (announces enhanced organizational structure)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: BBAI -27.3%, PUBM -23%, CE -13.2%, YALA -11.8%, FLNC -11.4%, ACVA -9.9%, DSP -7.3%, KODK -6.9%, ACHR -3.8%, HPK -3.1%, HI -1.7%, CMP -1.3%, OKLO -0.3%, CNNE -0.1%

Companies trading lower in after hours in reaction to news: SPXC -3.3% ($500 mln stock offering), WT -3.1% ($400 mln convertible notes offering), VIAV -1.9% (files mixed securities shelf offering), HRB -0.8% (CEO to retire; Curtis Campbell to be promoted to CEO, starting Jan 1), DEI -0.5% (files mixed securities shelf offering), FULT -0.4% (files mixed securities shelf offering), OKLO -0.3% (OKLO and LTBR announce collaboration to explore co-location of fuel fabrication facility), MRT -0.2% (stock offering by selling shareholders), CNS -0.1% (reports July AUM), EQBK -0.1% (stock offering by selling shareholders)

>>> Europe : Brokers Upgrades & Downgrades - 11th of August 2025 V2(+)

>>> Up
* Admiral Raised to Equal-Weight at Morgan Stanley; PT 3,300 pence
* Airbnb Raised to Buy at DBS Bank; PT $165
* Airbnb Raised to Neutral at Phillip Secs; PT $127
* Asmodee Raised to Buy at SEB Equities; PT 145 kronor
* Chesnara Raised to Buy at Peel Hunt
* Corbion Raised to Neutral at Van Lanschot Kempen; PT 16 euros
* Demant Raised to Buy at ABG; PT 315 kroner
* Disney Raised to Buy at DBS Bank; PT $135
* Freeport Raised to Overweight at Morgan Stanley; PT $48
* KBC Raised to Buy at BofA; PT 115 euros (+)
* Maersk PT Raised to 8,450 kroner from 7,800 kroner at JPMorgan
* Recordati Raised to Buy at Jefferies; PT 61.50 euros
* Symrise Raised to Buy at Baader Helvea; PT 100 euros
* Zurich Ins. Raised to Buy at Octavian; PT 640 Swiss francs (+)

>>> Down
* C3.ai Cut to Underperform at DA Davidson; PT $13
* C3.ai Cut to Reduce at President Capital Management; PT $18.40 (+)
* Elementis Cut to Neutral at JPMorgan; PT 186 pence
* Glaston Cut to Reduce at Inderes; PT 1.25 euros
* Just Group Cut to Hold at Jefferies; PT 219.20 pence
* NN Group Cut to Neutral at BofA (+)
* R&S Group Holding Cut to Hold at Octavian; PT 35.50 Swiss francs (+)
* Sandvik Cut to Sell at Nordea; PT 210 kronor
* Spindox Cut to Neutral at Banca Akros (+)
* Technip Energies Cut to Hold at Fearnley; PT 44 euros
* WithSecure Cut to Hold at Nordea

>>> Initiation
* Metlen Energy & Metals Rated New Overweight at Morgan Stanley
* Sea1 offshore Inc Rated New Buy at ABG; PT 38 kroner
* Yu Group Rated New Buy at Cavendish; PT 2,677 pence (+)

>>> Call
* Admiral Raised at Morgan Stanley, Investment Case More Balanced
* Elementis Upside More Limited After Rally, JPMorgan Downgrades
* Recordati Raised to Buy at Jefferies, Momentum Being Masked

NY POst : Ozempic users aged backwards by more than 3 years in new trial

Ozempic users aged backwards by more than 3 years in new trial

An astonishing new trial suggests that Ozempic may help users not only drop pounds but also turn back time.

In the first trial to directly measure the impact of semaglutide on aging, half of the participants were given a weekly injection of Ozempic while the other half received a placebo for 32 weeks.

“Those on semaglutide drug became, on average, 3.1 years biologically younger by the end of the study,” diagnostic researcher Varun Dwaraka reported.

The placebo group showed no significant change in biological age over the same period.

While everyone knows their chronological age, medical experts often speak in terms of biological or “phenotypic” age, which measures factors like metabolism, inflammation, and organ function.

Researchers note that the anti-aging effects of GLP-1 varied across the body’s systems. The most dramatic improvements were to the brain and inflammatory system, where the drug, originally developed to treat diabetes, appeared to delay biological aging by nearly 5 years.

The teams also noted significant improvement in the heart and kidneys.

“The drug may not only slow the rate of aging, but in some individuals partially reverse it,” Dwaraka said.

Researchers believe these powerful anti-aging qualities are related to Ozempic’s effect on fat distribution and metabolic health. In essence, excess fat around the body’s organs promotes the release of pro-aging molecules.

Obesity causes low-grade chronic inflammation, which is when the body’s natural chemical response to an irritant or injury remains active long after the threat has passed.

GLP-1 drugs indirectly reduce inflammation through weight loss. The meds can also activate specific T cells — white blood cells key to the immune system — which can have anti-inflammatory effects.

By reducing excess fat and inflammation, two hallmarks of epigenetic aging, the drug effectively slows the cruel march of deterioration.

The use of GLP-1 medications has proliferated in recent years. A recent KFF health poll revealed that 12% of US adults have taken an Ozempic-like drug at some point.

Despite the promising results, Dwaraka said caution and patience are called for.

“Prescribing it more broadly as an anti-ageing therapy is premature,” he said.

However, he and his team are hopeful their research will inspire further studies and support the repurposing of existing drugs to treat age-related problems, as these established medications are more likely to be fast-tracked for approval and come without the risk of unforeseen side effects.

“Semaglutide may well emerge as one of the most promising candidates in this space,” Dwaraka concluded.
GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk and decreased cancer risk to addiction treatment.

>>> What to look at today - 7th of August 2025

quity-index futures for the US and Europe rose and oil declined on speculation a meeting between US and Russian leaders will increase the chances of ending the war in Ukraine and boost crude supply. Contracts for European shares and the S&P 500 Index climbed 0.2%. Oil fell 0.6% while gold also dropped as US President Donald Trump prepared to meet his Russian counterpart Vladimir Putin on Friday. Asian shares rose 0.3% while a gauge of the dollar weakened 0.2%. Bitcoin rose as much as 3.2% to top $122,000 to come within striking distance of a record-high. There’s no cash trading in Treasuries in Asia due to a holiday in Japan. Asian lithium stocks rose while most chip shares retreated. Financial markets are drawing comfort from the prospect of an end to the three-year war in Ukraine, following a flurry of weekend diplomacy. European nations are seeking talks with Trump ahead of his upcoming meeting in Alaska. Trump had earlier threatened sanctions—and penalties—on countries like India for purchasing oil from Russia, prompting Putin to hold phone calls with Narendra Modi and other world leaders. Diplomatic negotiations were in full swing during the weekend with National security advisers from Europe, Ukraine and the US meeting in the UK and making significant progress toward the ending of the fighting.  The talks followed an earlier call between Ukraine President Volodymyr Zelenskiy and UK Prime Minister Keir Starmer, and a flurry of diplomacy involving Zelenskiy and other European leaders.
Goldman Sachs’ Hui Shan discusses the Chinese economic situation as President Xi Jinping’s “anti-involution” campaign aimed at curbing aggressive competition in the country is underway. Brent traded near $66 a barrel, after sliding 4.4% last week, while West Texas Intermediate was above $63. A peace deal with Ukraine could see an end to sanctions on supply from Russia, potentially exacerbating a glut forecast for later in the year.
In the crypto market, Bitcoin rose to within striking distance of an all-time high as demand from institutional investors and corporate treasury buyers lifts the wider market for digital assets. A weekend rally saw Ether surge to above $4,300, its highest level since Dec. 2021. Meanwhile, lithium prices and stocks spiked on Monday after battery giant Contemporary Amperex Technology Co. Ltd. halted operations at a major mine in China. Asia’s chip stocks fell after Nvidia Corp. and Advanced Micro Devices Inc. agreed to pay 15% of their revenues from chip sales to China to the US government as part of a deal with the Trump administration to secure export licenses. This week, investors await key economic data—especially the US inflation report—and a possible extension of the Aug. 12 deadline for US tariffs on Chinese exports. Ahead of the deadline, Trump posted on social media that he hoped China massively stepped up its purchases of American soybeans. Soybean futures in Chicago rose on Trump’s comments. Separately, Goldman Sachs analysts said US companies have so far absorbed most of the costs of Trump’s tariffs, but the burden is increasingly going to shift to consumers.

Nikkei Closed Hang Seng +0.10% CSI +0.57% Shanghai +0.48% Shenzen +1.43%

Eur$ 1.1673 CNH 7.1845 CNY 7.1804 JPY 147.48 GBP 1.3466 CHF 0.8064 RUB 79.9958 TRY 40.7437 WTI$ 63.42 -0.72% Gold 3,376 -0.64% BTC 122,003 +3.20% ETH 4,325 +2;60%

S&P +0.12% Nasdaq +0.10% EuroStoxx +0.11% FTSE +0.03% Dax +0.15% SMI +0.70%

Macro :
- Hedge Funds Are Unwinding Energy Bets That Dominated Since 2021
- White House to Clarify Misinformation on Gold Tariffs
- Bets on Sex Toy Stunts at WNBA Games Fuel Polymarket Critics
- US Hikes Another Canadian Lumber Duty, Bringing Total to 35.2%
- The Week’s 10 Biggest Funding Rounds: Public Safety Leads, While Healthcare And Fintech Also See Big Deals - CrunchBase
- The £77bn trade that risks throwing Britain into a doom-loop spira - Telegraph
- Zelensky Rejects Trump Proposal to Cede Territory to Russia

Keep an eye on :
- AMS LN : Advanced Medical Shares Up After Betaville ‘Uncooked Alert’
- AIR FP : Spirit AeroSystems to Sell Malaysian Plant, Business for $95m
- ARYN SW : Aryzta 1H Revenue EU1.09B Vs. EU1.06B Y/y
- BING GY : Boehringer Gets FDA Accelerated Approval for Hernexeos
- AI US : C3.ai Reports Sales Far Short of Estimates, Shakes Up Management
- DeepX IPO : AI Chip Firm DeepX Hires Morgan Stanley for Funding Before IPO
- FIG US : Figma’s $21 Billion Drop Returns Stock to Earth After IPO Frenzy
- HYQ GY : Hypoport 1H Ebit EU16.0M Vs. EU8.3M Y/y
- ICAD FP : Icade to Sell Stake in Portfolio of Assets in Italy for EU173m
- IDIA SW : Idorsia Publishes Interim Results of Bond Repurchase Offers
- IMXI US : Western Union to Buy International Money for $16 per Share
- LWAY US : A Family Feud Leaves the Future of This Kefir King in Doubt. Danone May Take Over - Barrons
- NFLX US : Netflix Explores Bid for Home Run Derby as ESPN Deal Ends
- NOVN SW : Novartis Ianalumab Phase 3 Trials Met Primary Endpoints
- NB2 GY : Rumble to Buy AI Company Northern Data
- NVDA US : Nvidia Allowed to Sell Chips to China After CEO Met Trump: FT
- NVDA US : Nvidia’s Quiet Rising Stars? The Son and Daughter of Billionaire Founder Jensen Huang - The Information
- NVDA US : Nvidia’s H20 Chips Raise Safety, Performance Concerns: CCTV
- NVDA US : Nvidia, AMD to Pay US 15% of China AI Chip Sales in Unusual Move
- NYXH BB : Nyxoah Wins FDA Nod for Cordless Sleep Apnea System
- ORSTED DC : Orsted Plans $9 Billion Rights Issue to Strenghen Balance Sheet
- PLTR US : Palantir’s 2,500% Run Has Bulls Scrambling to Justify Valuation
- PFE US : Arvinas, Pfizer Say Vepdegestrant NDA Accepted by FDA
- ROG SW : Swiss Leaders Seek Talks With Roche, Novartis After US Tariffs
- SZG GY : Salzgitter 1H Loss After Tax EU88.9M Vs. Loss EU18.6M Y/y
- SKX US : Skechers Puts Up Impressive 2Q Results Ahead of Go-Private
- TGNA US : Nexstar in Advanced Talks to Buy Tegna, Sources Say -- WSJ
- DG FP : Vinci Signs Final Accord to Acquire Cobra IS, to Pay ACS €300m
- VOYG US : Voyager Technologies Falls to IPO Price for First Time